DEPLETION OF C-MYC WITH SPECIFIC ANTISENSE SEQUENCES REVERSES THE TRANSFORMED PHENOTYPE IN RAS ONCOGENE-TRANSFORMED NIH 3T3 CELLS

被引:60
|
作者
SKLAR, MD
THOMPSON, E
WELSH, MJ
LIEBERT, M
HARNEY, J
GROSSMAN, HB
SMITH, M
PROCHOWNIK, EV
机构
[1] UNIV MICHIGAN,SCH MED,COMM CELL & MOLEC BIOL,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48109
[3] UNIV MICHIGAN,SCH MED,DEPT SURG,UROL SECT,ANN ARBOR,MI 48109
[4] UNIV MICHIGAN,SCH MED,DEPT RADIAT ONCOL,ANN ARBOR,MI 48109
[5] UNIV MICHIGAN,SCH MED,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109
关键词
D O I
10.1128/MCB.11.7.3699
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ras oncogene-transformed NIH 3T3 cells expressing glucocorticoid-inducible antisense c-myc cDNA transcripts at levels sufficient to deplete c-myc protein lost their transformed morphology and the ability to grow in soft agar; their ability to form tumors in nude mice was also impaired. These changes were dependent on the continuous expression of the antisense sequences. No major effects on plating efficiencies, growth rates in monolayer culture, or immortalization were observed in the revertant cells, indicating that the observed effects were not a toxic consequence of c-myc protein depletion. Transfection with the same vector expressing c-myc in the sense orientation or other control vectors had no effect on transformation. These results suggest that a certain minimum level of expression of c-myc is required for the maintenance of ras transformation in NIH 3T3 cells.
引用
收藏
页码:3699 / 3710
页数:12
相关论文
共 50 条
  • [21] EFFECT OF GLUCOCORTICOIDS ON ONCOGENE TRANSFORMED NIH3T3 CELLS
    MATIN, A
    CHENG, KL
    SUEN, TC
    HUNG, MC
    ONCOGENE, 1990, 5 (01) : 111 - 116
  • [22] A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines
    Chang, MY
    Won, SJ
    Liu, HS
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (02) : 91 - 99
  • [23] A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines
    Meng-Yao Chang
    Shen-Jeu Won
    Hsiao-Sheng Liu
    Journal of Cancer Research and Clinical Oncology, 1997, 123 : 91 - 99
  • [24] IMAGE-ANALYSIS OF FEULGEN-STAINED C-H-RAS-TRANSFORMED NIH/3T3 CELLS
    MELLO, MLS
    RUSSO, J
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1990, 68 (7-8): : 1026 - 1031
  • [25] A NOVEL COMPOUND, DEPUDECIN, INDUCES PRODUCTION OF TRANSFORMATION TO THE FLAT PHENOTYPE OF NIH3T3 CELLS TRANSFORMED BY RAS-ONCOGENE
    SUGITA, K
    YOSHIDA, H
    MATSUMOTO, M
    MATSUTANI, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 182 (01) : 379 - 387
  • [26] The role of substrate flexibility in the proliferation of normal and ras-transformed NIH 3T3 cells.
    Wang, HB
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 168A - 168A
  • [27] Phosphatidylethanolamine and phosphatidylcholine are sources of diacylglycerol in ras-transformed NIH 3T3 fibroblasts
    Momchilova, A
    Markovska, T
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (02): : 311 - 318
  • [28] GROWTH-FACTOR DEPENDENCE OF NIH 3T3-CELLS TRANSFORMED BY V-MYC ONCOGENE
    POSPELOVA, TV
    BLAGOSKLONNY, MV
    ZARITSKY, AY
    TSITOLOGIYA, 1990, 32 (04): : 358 - 363
  • [29] A SPECIFIC PROTEIN, P92, DETECTED IN FLAT REVERTANTS DERIVED FROM NIH/3T3 TRANSFORMED BY HUMAN ACTIVATED C-HA-RAS ONCOGENE
    FUJITA, H
    SUZUKI, H
    KUZUMAKI, N
    MULLAUER, L
    OGISO, Y
    ODA, A
    EBISAWA, K
    SAKURAI, T
    NONOMURA, Y
    KIJIMOTOOCHIAI, S
    EXPERIMENTAL CELL RESEARCH, 1990, 186 (01) : 115 - 121
  • [30] TUMORIGENICITY OF EJ-RAS ONCOGENE TRANSFORMED NIH-3T3 CELLS AND EXPRESSION OF PLASMINOGEN ACTIVATORS
    SIDHU, MK
    RUSSO, MS
    ZIRVI, KA
    SCALA, L
    KUMAR, S
    CELL BIOLOGY INTERNATIONAL REPORTS, 1990, 14 (06) : 527 - 542